Graph Therapeutics secures $5M led by Daphni, bringing total funding to over $10M to advance precision immunology.
Amount Raised
$5 Million
Round Type
Funding Round
Investors
Description
Graph Therapeutics has secured a new $5 million investment led by Daphni. This funding brings the company's total raised to over $10 million, enabling advancements in their drug discovery pipeline. The capital will enhance Graph’s capabilities in targeting inflammatory and immune-mediated diseases. Existing investors include SquareOne, Merantix Capital, and NAVEC Investment Management.
Quick answer
Graph Therapeutics raised $5 Million in a Funding Round round, dated June 22, 2026. Investors: SquareOne, Merantix Capital, Navec Investment Management and Daphni.
- How much did Graph Therapeutics raise?
- Graph Therapeutics raised $5 Million in a Funding Round round on June 22, 2026.
- Who invested in Graph Therapeutics?
- SquareOne, Merantix Capital, Navec Investment Management and Daphni are named as investors in this round.
- What does Graph Therapeutics do?
- Graph Therapeutics is a next-generation techbio company developing precision medicines for inflammatory and immune-mediated diseases.
- Where is Graph Therapeutics based and how big is it?
- Fundz records about 16 employees.
- Who are the decision-makers at Graph Therapeutics?
- Fundz holds 1 contact at Graph Therapeutics, including the Co-founder, CSO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Graph Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Kordata Dynamics raised an undisclosed amount (Pre-Seed) on May 21, 2026.
- Nano-X Imaging Ltd. raised $8M (Post-IPO Equity) on August 6, 2026.
- Mediqstar raised an undisclosed amount (Series B) on August 3, 2026.
- Safe Superintelligence raised $3B (Convertible Note) on July 27, 2026.
- InnoDtech raised $3.4M (Seed) on July 23, 2026.
- Transcripta Bio raised $24M (Series A) on July 22, 2026.
Who to call at Graph Therapeutics, and when
A new round usually means Graph Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Graph Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Graph Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Graph Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Graph Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Graph Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.